HEADER VIRAL PROTEIN 06-AUG-18 6H9Y TITLE UNRAVELING THE ROLE OF THE SECRETOR ANTIGEN IN HUMAN ROTAVIRUS TITLE 2 ATTACHMENT TO HISTO-BLOOD GROUP ANTIGENS COMPND MOL_ID: 1; COMPND 2 MOLECULE: OUTER CAPSID PROTEIN VP4; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: G1 AND S2 ARE RESIDUALS FROM TAG DIGESTION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN ROTAVIRUS A; SOURCE 3 ORGANISM_TAXID: 10941; SOURCE 4 GENE: VP4; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS HISTO-BLOOD GROUP ANTIGEN ROTAVIRUS, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.R.CIGES-TOMAS,R.GOZALBO-ROVIRA,S.VILA-VICENT,J.BUESA,C.SANTISO- AUTHOR 2 BELLON,V.MONEDERO,M.J.YEBRA,J.RODRIGUEZ-DIAZ,A.MARINA REVDAT 4 17-JAN-24 6H9Y 1 HETSYN LINK REVDAT 3 29-JUL-20 6H9Y 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 03-JUL-19 6H9Y 1 JRNL REVDAT 1 12-JUN-19 6H9Y 0 JRNL AUTH R.GOZALBO-ROVIRA,J.R.CIGES-TOMAS,S.VILA-VICENT,J.BUESA, JRNL AUTH 2 C.SANTISO-BELLON,V.MONEDERO,M.J.YEBRA,A.MARINA, JRNL AUTH 3 J.RODRIGUEZ-DIAZ JRNL TITL UNRAVELING THE ROLE OF THE SECRETOR ANTIGEN IN HUMAN JRNL TITL 2 ROTAVIRUS ATTACHMENT TO HISTO-BLOOD GROUP ANTIGENS. JRNL REF PLOS PATHOG. V. 15 07865 2019 JRNL REFN ESSN 1553-7374 JRNL PMID 31226167 JRNL DOI 10.1371/JOURNAL.PPAT.1007865 REMARK 2 REMARK 2 RESOLUTION. 1.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 60807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3204 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 512 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.35000 REMARK 3 B22 (A**2) : -0.29000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.42000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.063 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.065 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6H9Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1200011331. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97907 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.31 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64030 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.310 REMARK 200 RESOLUTION RANGE LOW (A) : 66.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6H9W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M LI2SO4 0.1M TRIS PH6.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.36250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 225 REMARK 465 SER B 226 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 262 -57.60 -130.04 REMARK 500 ASP A 296 33.11 -98.09 REMARK 500 ASN A 355 71.86 -153.19 REMARK 500 ASN B 261 17.67 58.57 REMARK 500 SER B 262 -63.03 -129.33 REMARK 500 REMARK 500 REMARK: NULL DBREF1 6H9Y A 228 386 UNP A0A2K9UWM4_9REOV DBREF2 6H9Y A A0A2K9UWM4 65 223 DBREF1 6H9Y B 228 386 UNP A0A2K9UWM4_9REOV DBREF2 6H9Y B A0A2K9UWM4 65 223 SEQADV 6H9Y GLY A 225 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y SER A 226 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y MET A 227 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y ASN A 323 UNP A0A2K9UWM ASP 160 CONFLICT SEQADV 6H9Y GLY B 225 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y SER B 226 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y MET B 227 UNP A0A2K9UWM EXPRESSION TAG SEQADV 6H9Y ASN B 323 UNP A0A2K9UWM ASP 160 CONFLICT SEQRES 1 A 162 GLY SER MET LEU ASP GLY PRO TYR GLN PRO THR THR PHE SEQRES 2 A 162 THR PRO PRO SER ASP TYR TRP ILE LEU ILE ASN SER ASN SEQRES 3 A 162 THR ASN GLY VAL VAL TYR GLU SER THR ASN ASN SER ASP SEQRES 4 A 162 PHE TRP THR ALA VAL ILE ALA VAL GLU PRO HIS VAL ASP SEQRES 5 A 162 PRO VAL ASP ARG GLN TYR ASN VAL PHE GLY GLU ASN LYS SEQRES 6 A 162 GLN PHE ASN VAL ARG ASN ASP SER ASP LYS TRP LYS PHE SEQRES 7 A 162 LEU GLU MET PHE ARG GLY SER SER GLN ASN ASP PHE TYR SEQRES 8 A 162 ASN ARG ARG THR LEU THR SER ASN THR ARG LEU VAL GLY SEQRES 9 A 162 ILE LEU LYS TYR GLY GLY ARG ILE TRP THR PHE HIS GLY SEQRES 10 A 162 GLU THR PRO ARG ALA THR THR ASP SER SER ASN THR ALA SEQRES 11 A 162 ASN LEU ASN GLY ILE SER ILE THR ILE HIS SER GLU PHE SEQRES 12 A 162 TYR ILE ILE PRO ARG SER GLN GLU SER LYS CYS ASN GLU SEQRES 13 A 162 TYR ILE ASN ASN GLY LEU SEQRES 1 B 162 GLY SER MET LEU ASP GLY PRO TYR GLN PRO THR THR PHE SEQRES 2 B 162 THR PRO PRO SER ASP TYR TRP ILE LEU ILE ASN SER ASN SEQRES 3 B 162 THR ASN GLY VAL VAL TYR GLU SER THR ASN ASN SER ASP SEQRES 4 B 162 PHE TRP THR ALA VAL ILE ALA VAL GLU PRO HIS VAL ASP SEQRES 5 B 162 PRO VAL ASP ARG GLN TYR ASN VAL PHE GLY GLU ASN LYS SEQRES 6 B 162 GLN PHE ASN VAL ARG ASN ASP SER ASP LYS TRP LYS PHE SEQRES 7 B 162 LEU GLU MET PHE ARG GLY SER SER GLN ASN ASP PHE TYR SEQRES 8 B 162 ASN ARG ARG THR LEU THR SER ASN THR ARG LEU VAL GLY SEQRES 9 B 162 ILE LEU LYS TYR GLY GLY ARG ILE TRP THR PHE HIS GLY SEQRES 10 B 162 GLU THR PRO ARG ALA THR THR ASP SER SER ASN THR ALA SEQRES 11 B 162 ASN LEU ASN GLY ILE SER ILE THR ILE HIS SER GLU PHE SEQRES 12 B 162 TYR ILE ILE PRO ARG SER GLN GLU SER LYS CYS ASN GLU SEQRES 13 B 162 TYR ILE ASN ASN GLY LEU HET NAG C 1 15 HET GAL C 2 11 HET BTB B 401 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN BTB BIS-TRIS BUFFER FORMUL 3 NAG C8 H15 N O6 FORMUL 3 GAL C6 H12 O6 FORMUL 4 BTB C8 H19 N O5 FORMUL 5 HOH *512(H2 O) HELIX 1 AA1 GLN A 374 GLY A 385 1 12 HELIX 2 AA2 GLN B 374 GLY B 385 1 12 SHEET 1 AA111 ASP A 229 TYR A 232 0 SHEET 2 AA111 PHE A 367 PRO A 371 -1 O ILE A 369 N ASP A 229 SHEET 3 AA111 TYR A 243 ASN A 248 -1 N LEU A 246 O TYR A 368 SHEET 4 AA111 LEU A 326 TYR A 332 -1 O VAL A 327 N ILE A 247 SHEET 5 AA111 ARG A 335 GLU A 342 -1 O TRP A 337 N LEU A 330 SHEET 6 AA111 TYR A 315 SER A 322 1 N THR A 321 O GLY A 341 SHEET 7 AA111 TRP A 300 ARG A 307 -1 N TRP A 300 O SER A 322 SHEET 8 AA111 TRP A 265 VAL A 271 -1 N ALA A 267 O MET A 305 SHEET 9 AA111 GLY A 253 THR A 259 -1 N VAL A 255 O VAL A 268 SHEET 10 AA111 SER A 360 ILE A 363 -1 O THR A 362 N GLU A 257 SHEET 11 AA111 THR A 236 PHE A 237 -1 N PHE A 237 O ILE A 361 SHEET 1 AA2 6 ASP A 229 TYR A 232 0 SHEET 2 AA2 6 PHE A 367 PRO A 371 -1 O ILE A 369 N ASP A 229 SHEET 3 AA2 6 TYR A 243 ASN A 248 -1 N LEU A 246 O TYR A 368 SHEET 4 AA2 6 LEU A 326 TYR A 332 -1 O VAL A 327 N ILE A 247 SHEET 5 AA2 6 ARG A 335 GLU A 342 -1 O TRP A 337 N LEU A 330 SHEET 6 AA2 6 THR A 347 SER A 351 -1 O THR A 347 N HIS A 340 SHEET 1 AA3 2 VAL A 275 VAL A 284 0 SHEET 2 AA3 2 GLU A 287 ASN A 295 -1 O VAL A 293 N VAL A 278 SHEET 1 AA411 ASP B 229 TYR B 232 0 SHEET 2 AA411 GLU B 366 PRO B 371 -1 O ILE B 369 N ASP B 229 SHEET 3 AA411 TYR B 243 ASN B 248 -1 N TRP B 244 O ILE B 370 SHEET 4 AA411 LEU B 326 TYR B 332 -1 O VAL B 327 N ILE B 247 SHEET 5 AA411 ARG B 335 GLU B 342 -1 O TRP B 337 N LEU B 330 SHEET 6 AA411 TYR B 315 SER B 322 1 N THR B 321 O GLY B 341 SHEET 7 AA411 TRP B 300 ARG B 307 -1 N TRP B 300 O SER B 322 SHEET 8 AA411 TRP B 265 VAL B 271 -1 N ALA B 267 O MET B 305 SHEET 9 AA411 GLY B 253 THR B 259 -1 N VAL B 255 O VAL B 268 SHEET 10 AA411 SER B 360 ILE B 363 -1 O THR B 362 N GLU B 257 SHEET 11 AA411 THR B 235 PHE B 237 -1 N PHE B 237 O ILE B 361 SHEET 1 AA5 6 ASP B 229 TYR B 232 0 SHEET 2 AA5 6 GLU B 366 PRO B 371 -1 O ILE B 369 N ASP B 229 SHEET 3 AA5 6 TYR B 243 ASN B 248 -1 N TRP B 244 O ILE B 370 SHEET 4 AA5 6 LEU B 326 TYR B 332 -1 O VAL B 327 N ILE B 247 SHEET 5 AA5 6 ARG B 335 GLU B 342 -1 O TRP B 337 N LEU B 330 SHEET 6 AA5 6 THR B 347 SER B 351 -1 O THR B 347 N HIS B 340 SHEET 1 AA6 2 VAL B 275 VAL B 284 0 SHEET 2 AA6 2 GLU B 287 ASN B 295 -1 O PHE B 291 N ARG B 280 LINK O3 NAG C 1 C1 GAL C 2 1555 1555 1.43 CISPEP 1 GLY A 230 PRO A 231 0 5.43 CISPEP 2 THR A 343 PRO A 344 0 11.75 CISPEP 3 GLY B 230 PRO B 231 0 1.15 CISPEP 4 THR B 343 PRO B 344 0 5.32 CRYST1 38.988 54.725 67.433 90.00 97.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025649 0.000000 0.003567 0.00000 SCALE2 0.000000 0.018273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014972 0.00000